Transplantation and cellular therapy

Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study.

Transplantation and cellular therapy

Hudda Z, Webster A, Anderson E, Badia P, Bagatell R, Bhar S, Bidgoli A, Boyd K, Chaudhury S, Cisneros GS, Craddock J, Davies SM, Desai AV, Drobatz L, Dvorak CC, Elkus H, Fabrizio VA, Foster JH, Fraint E, Freedman JL, Galvez J, Garcia M, Haight A, Higham C, Jodele S, Kamat A, Kaviany S, Lehmann L, Leung K, Lind KT, Llaurador G, Kapadia M, Khazal S, Massi K, Mormann M, Pater L, Rangarajan HG, Rotz S, Sabulski A, Sartain SE, Schoettler ML, Sokol E, Streby KA, Stein M, Verneris MR, Weiss BD, Yazdani S, Zheng D, Dandoy CE

Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study.

Transplantation and cellular therapy

Switzer GE, Bruce JG, Shaw BE, Kuniyil V, Varni JW, Butler BJ, Erickson C, Mussetter A, Neutzling A, Abdel-Azim H, Aguayo-Hiraldo P, Anderson EJ, Aquino VM, Boone K, Boulad F, Chewning JH, Cooper J, Dahlberg A, Dvorak CC, Galvez-Silva J, Haight AE, Hoag JA, Hudspeth M, Jacobsohn D, Kasow KA, Kitko CL, Krishnamurti L, Madden L, Miller HK, Morales E, Olson TS, Pawlowska AB, Prasad VK, Quigg TC, Scaradavou A, Shah NC, Shenoy S, Terwilliger NB, Wiener L, Yanik GA, Yu LC, Pulsipher MA

Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response Assessment.

Transplantation and cellular therapy

Schoettler ML, Cheng G, Higham CS, Dvorak CC, Rush C, Rangarajan HG, Al-Nazer M, Polishchuk V, Chaudhury S, Lehmann L, Duncan C, Nishitani M, Manougian H, Rotz S, Ofori J, Frost E, Orbodo J, Spencer K, Kenney E, Chonat S, Chewning J, Moore C, Westbrook A, Williams KM